Background: Compared to non-recurrent type, recurrent prostate adenocarcinoma (PCa) is
highly fatal, and significantly shortens the survival time of affected patients. Early and …

The recurrence of prostate cancer (PCa) is intrinsically linked to increased mortality. The
goal of this study was to develop an efficient and reliable prognosis prediction signature for …

Abstract Background Prostate cancer (PCa) is the second leading cause of cancer death in
men in 2018. Thus, the evaluation of prognosis is crucial for clinical treatment decision of …

Prostate cancer (PCa) is the second most common male cancer worldwide but effective
biomarkers for the presence or progression-risk of disease are currently elusive. We carried …

Prostate cancer (PCa) is a leading cause of cancer-related mortality worldwide. Gleason
score (GS) is one of the best predictors of PCa aggressiveness, but additional tumor …

Currently, no ideal prostate cancer (PCa) diagnostic or prognostic test is available due to the
lack of biomarkers with high sensitivity and specificity. There is an unmet medical need to …

One of the major challenges in the development of prostate cancer prognostic biomarkers is
the cellular heterogeneity in tissue samples. We developed an objective Cluster-Correlation …

Prostate cancer (PCa) is one of the most deadly urinary tumors in men globally, and the 5‐
year over survival is poor due to metastasis of tumor. It is significant to explore potential …

Background: This study aimed to identify biomarkers for estimating the overall and prostate
cancer (PCa)-specific survival in PCa patients at diagnosis. Methods: To explore the …

Background: Prostate cancer (PCa) is a malignancy of the urinary system with a high
incidence, which is the second most common male cancer in the world. There are still huge …